BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 29689621)

  • 1. SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes.
    E Hermosilla V; Salgado G; Riffo E; Escobar D; Hepp MI; Farkas C; Galindo M; Morín V; García-Robles MA; Castro AF; Pincheira R
    Mol Oncol; 2018 Jun; 12(7):1026-1046. PubMed ID: 29689621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cancer/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner.
    Por E; Byun HJ; Lee EJ; Lim JH; Jung SY; Park I; Kim YM; Jeoung DI; Lee H
    J Biol Chem; 2010 May; 285(19):14475-85. PubMed ID: 20220142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.
    Farkas C; Martins CP; Escobar D; Hepp MI; Castro AF; Evan G; Gutiérrez JL; Warren R; Donner DB; Pincheira R
    PLoS One; 2013; 8(9):e73817. PubMed ID: 24040083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
    Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
    Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.
    Tenderenda M
    J Exp Clin Cancer Res; 2005 Sep; 24(3):405-14. PubMed ID: 16270527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone-induced cell proliferation in GC cells is mediated by changes in G1 cyclin/cyclin-dependent kinase levels and activity.
    Barrera-Hernandez G; Park KS; Dace A; Zhan Q; Cheng SY
    Endocrinology; 1999 Nov; 140(11):5267-74. PubMed ID: 10537157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transcriptional regulation of cyclins D1, D3 and G1 and proliferation of human cancer cells depend on IMP-3 nuclear localization.
    Rivera Vargas T; Boudoukha S; Simon A; Souidi M; Cuvellier S; Pinna G; Polesskaya A
    Oncogene; 2014 May; 33(22):2866-75. PubMed ID: 23812426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis.
    Al-Aynati MM; Radulovich N; Ho J; Tsao MS
    Clin Cancer Res; 2004 Oct; 10(19):6598-605. PubMed ID: 15475449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
    Hsiang CH; Straus DS
    Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-type cyclins and G1 progression during liver development in the rat.
    Boylan JM; Gruppuso PA
    Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.
    Ye L; Guo L; He Z; Wang X; Lin C; Zhang X; Wu S; Bao Y; Yang Q; Song L; Lin H
    Oncotarget; 2016 Apr; 7(17):23757-71. PubMed ID: 26992224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.
    Lu D; Wolfgang CD; Hai T
    J Biol Chem; 2006 Apr; 281(15):10473-81. PubMed ID: 16469745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NEUROG2 drives cell cycle exit of neuronal precursors by specifically repressing a subset of cyclins acting at the G1 and S phases of the cell cycle.
    Lacomme M; Liaubet L; Pituello F; Bel-Vialar S
    Mol Cell Biol; 2012 Jul; 32(13):2596-607. PubMed ID: 22547683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.
    Chen L; Wei T; Si X; Wang Q; Li Y; Leng Y; Deng A; Chen J; Wang G; Zhu S; Kang J
    J Biol Chem; 2013 May; 288(20):14510-14521. PubMed ID: 23543735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression.
    Borowiec AS; Hague F; Gouilleux-Gruart V; Lassoued K; Ouadid-Ahidouch H
    Biochim Biophys Acta; 2011 May; 1813(5):723-30. PubMed ID: 21315112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1, cancer progression, and opportunities in cancer treatment.
    Qie S; Diehl JA
    J Mol Med (Berl); 2016 Dec; 94(12):1313-1326. PubMed ID: 27695879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
    Sinibaldi D; Wharton W; Turkson J; Bowman T; Pledger WJ; Jove R
    Oncogene; 2000 Nov; 19(48):5419-27. PubMed ID: 11114718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.